Case Study: a specialty pharma company develops an orphan drug launch strategy with Axtria

A Axtria Case Study

Preview of the A Specialty Pharma Company Case Study

Specialty Pharma Company improves orphan drug launch targeting with Axtria

The specialty pharma company was preparing to launch a novel orphan drug for a rare disease but faced significant challenges. Their business team struggled to define the target patient population, identify top treaters, and understand the treatment journey due to high misdiagnosis rates and a complex diagnostic process. They engaged vendor Axtria to develop a product launch strategy.

Axtria developed a comprehensive go-to-market strategy for the client, which included determining sales force size and structure, segmentation, targeting, and alignment. This solution enabled efficient targeting through a precise patient pool determination and the identification of key thought leaders. Axtria's efforts resulted in a robust execution strategy that ensured the best possible coverage of primary and opportunistic targets for a successful product launch.


View this case study…

Axtria

96 Case Studies